USPTO serial 77340529
ESCOZINE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CASE, LEIGH CAROLINE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ESCOZINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Beverly Hills, CA
Beverly Hills, CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Adjuvants for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for nutritional purposes; Analgesic balm; Analgesic preparations; Analgesics; Animal feed additive for use as a nutritional supplement for medical purposes; Anti-inflammatories; Anti-inflammatory and antipyretic preparations; Biological preparations for medical purposes; Calcium channel blockers; Chewing gum for medical purposes; Dental rinse; Dermatological pharmaceutical products; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietary supplements for animals; Dietary supplements for human consumption; Dietetic foods adapted for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ear drops; Eye drops; Eye washes; Food supplements; Food supplements, namely, anti-oxidants; Herb teas for medicinal purposes; Herbal supplements; Herbal teas for medicinal purposes; Herbs for medicinal purposes; Homeopathic pharmaceuticals for use in the treatment of cancer; Homeopathic supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicated animal feed; Medicated candies; Medicated chewing gum; Medicated chewing gum for cancer; Medicated gum for cancer; Medicated lotions for cancer; Medicated lozenges; Medicated mouth care and treatment preparations; Medicated mouthwash; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin preparation for use in treating cancer; Medicinal creams for skin care; Medicinal drinks; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal tea; Medicines for the treatment of gastrointestinal diseases; Mineral food supplements; Mineral nutritional supplements; Mineral salts for medical purposes; Mineral supplements; Mixed vitamin preparations; Mold inhibitors for treating mold growth in and around buildings; Mole skin for use as a medical bandage; Muscle relaxants; Muscle soaks; Nail fungus treatment preparations; Nasal and oral spray preparations for use as central nervous system stimulants; Multi-vitamin preparations; Multivitamin preparations; Nutraceuticals for the treatment of cancer; Nutraceuticals for use as a dietary supplement; Nutritional additives for livestock feed for medical purposes; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional additives to foodstuffs for animals, for medical purposes; Nutritional drinks for animals; Nutritional oils not for food or cosmetic purposes; Nutritional supplements; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritionally fortified beverages; Nutritionally fortified water; Oral analgesics; Pain relief medication; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for treating skin disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Plant extracts for medical, veterinary and pharmaceutical purposes; Pre-moistened medicated towelettes; Processed food adapted for medical purposes; Products and preparations for cleansing the skin for medical use; Topical analgesics; Topical gel for medical and therapeutic treatment of cancer; Tumor suppressing agents; Veterinary preparations, namely, pain relief medication; Vitamin B preparations; Vitamin C preparations; Vitamin D preparations; Vitamin and mineral preparations for medical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin and mineral supplements; Vitamin drops; Vitamin enriched water; Vitamin fortified beverages; Vitamin preparations; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 24, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 13, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 13, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 23, 2009 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Apr 23, 2009 | PETG | PETITION TO REVIVE-GRANTED | — |
| Apr 23, 2009 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Feb 23, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 23, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 22, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 22, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 29, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 9, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 27, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 25, 2008 | ALIE | ASSIGNED TO LIE | — |
| Mar 11, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 11, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2007 | NWAP | NEW APPLICATION ENTERED | — |